Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pascolizumab in pulmonary tuberculosis
NCT01638520Phase 2Unknown
- Sponsor
- National University Hospital
- Start
- Jun 2012
- Primary completion
- Feb 2017
- Modality
- Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 2 trial of pascolizumab in Tuberculosis (TB), sponsored by National University Hospital. Status: unknown.
02
Drugs
pascolizumab
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT01638520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01638520.